GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioNeutra Global Corp (TSXV:BGA) » Definitions » Gross Profit

BioNeutra Global (TSXV:BGA) Gross Profit : C$4.27 Mil (TTM As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is BioNeutra Global Gross Profit?

BioNeutra Global's gross profit for the three months ended in Mar. 2024 was C$0.52 Mil. BioNeutra Global's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was C$4.27 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. BioNeutra Global's gross profit for the three months ended in Mar. 2024 was C$0.52 Mil. BioNeutra Global's Revenue for the three months ended in Mar. 2024 was C$2.46 Mil. Therefore, BioNeutra Global's Gross Margin % for the quarter that ended in Mar. 2024 was 21.11%.

BioNeutra Global had a gross margin of 21.11% for the quarter that ended in Mar. 2024 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of BioNeutra Global was 47.21%. The lowest was 1.69%. And the median was 25.06%.


BioNeutra Global Gross Profit Historical Data

The historical data trend for BioNeutra Global's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNeutra Global Gross Profit Chart

BioNeutra Global Annual Data
Trend Feb14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.64 3.94 2.89 2.35 4.14

BioNeutra Global Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.39 0.89 2.47 0.52

Competitive Comparison of BioNeutra Global's Gross Profit

For the Packaged Foods subindustry, BioNeutra Global's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNeutra Global's Gross Profit Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioNeutra Global's Gross Profit distribution charts can be found below:

* The bar in red indicates where BioNeutra Global's Gross Profit falls into.



BioNeutra Global Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

BioNeutra Global's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=11.383 - 7.24
=4.14

BioNeutra Global's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=2.458 - 1.939
=0.52

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$4.27 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

BioNeutra Global's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.52 / 2.458
=21.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


BioNeutra Global  (TSXV:BGA) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

BioNeutra Global had a gross margin of 21.11% for the quarter that ended in Mar. 2024 => Competition eroding margins


BioNeutra Global Gross Profit Related Terms

Thank you for viewing the detailed overview of BioNeutra Global's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNeutra Global (TSXV:BGA) Business Description

Traded in Other Exchanges
Address
9608 - 25 Avenue NW, Edmonton, AB, CAN, T6N 1J4
BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.
Executives
Monica Barclay Senior Officer

BioNeutra Global (TSXV:BGA) Headlines

No Headlines